PubRank

Takayuki Iwamoto

Author PubWeight™ 29.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat 2011 1.90
2 Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. J Clin Oncol 2010 1.63
3 Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells. Proc Natl Acad Sci U S A 2012 1.45
4 Inflammatory breast cancer: what we know and what we need to learn. Oncologist 2012 1.41
5 The outcome of living donor liver transplantation with prior spontaneous large portasystemic shunts. Transpl Int 2007 1.32
6 Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clin Cancer Res 2013 1.30
7 Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer. Oncologist 2012 1.18
8 Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 2008 1.12
9 Preoperative proximal splenic artery embolization: a safe and efficacious portal decompression technique that improves the outcome of live donor liver transplantation. Transpl Int 2007 1.06
10 DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes. Oncologist 2013 1.04
11 Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures. PLoS One 2011 1.03
12 Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. Cancer Sci 2012 1.01
13 Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer. Clin Cancer Res 2012 1.00
14 Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women. BMC Cancer 2013 0.98
15 Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer. Cancer Res 2010 0.96
16 Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers. Breast Cancer Res 2013 0.92
17 Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers. Clin Cancer Res 2011 0.92
18 Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers. Breast Cancer Res Treat 2013 0.90
19 Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers. Breast Cancer Res 2013 0.86
20 Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problems. BMC Bioinformatics 2011 0.86
21 TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. Cancer Res 2013 0.82
22 Association between mammographic breast density and lifestyle in Japanese women. Acta Med Okayama 2013 0.80
23 A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories. Breast Cancer Res Treat 2013 0.80
24 Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancer. Oncologist 2011 0.79
25 Correlation between 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography and Clinicopathological Features in Invasive Ductal Carcinoma of the Breast. Acta Med Okayama 2015 0.78
26 Breast cancer prognostic markers in the post-genomic era. Breast Cancer Res Treat 2010 0.77
27 Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer:NACED-Randomized Multicenter Phase II Trial. Acta Med Okayama 2015 0.76
28 Preoperative assessment of the risk factors that help to predict the prognosis after living donor liver transplantation. World J Surg 2008 0.76
29 Bayesian mixture models for assessment of gene differential behaviour and prediction of pCR through the integration of copy number and gene expression data. PLoS One 2013 0.75
30 A Phase I Trial of 100 mg/m2 Docetaxel in Patients with Advanced or Recurrent Breast Cancer. Acta Med Okayama 2016 0.75
31 Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment. Breast Cancer 2011 0.75
32 Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma. Dig Dis 2016 0.75
33 Laparoscopic tailored Nissen fundoplication. Surg Endosc 2010 0.75